Vertex Pharmaceuticals Inc / Ma Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -642.18M-754.63M41.18M-139.30M-183.93M-0.91M-588.18M-84.03M91.64M2087.10M1176.80M2711.70M2342.10M3322.00M3619.60M-535.60M
Depreciation and Depletion 28.30M27.90M28.90M35.70M47.30M62.30M60.00M60.80M61.40M72.40M106.90M109.50M125.60M148.30M167.80M160.40M
Share-based Compensation 86.72M91.12M118.23M114.28M127.30M177.54M231.03M240.62M293.24M325.05M360.50M429.50M441.40M491.30M581.20M698.50M
Deferred Taxes -2.23M-7.50M36.66M-285.05M0.28M3.28M16.96M-120.51M-1512.33M167.40M277.30M-154.60M-275.90M-536.50M-348.80M
Gains from Sales and Divestitures 0.54M0.75M
Gains from Investment Securities 19.23M21.29M23.07M31.10M-55.11M9.19M21.93M-6.14M-76.64M-33.58M39.20M200.30M476.30M1057.80M1677.30M1082.10M
Asset Writedowns and Impairment 7.20M0.62M105.80M133.19M10.40M1.69M2.52M255.34M29.00M
Cash from Restructuring -0.05M-4.42M-3.28M-2.98M5.03M17.50M-30.49M-7.43M-5.99M
Non-cash Items 12.77M56.38M
Cash from Operations -427.59M-635.44M143.74M267.84M-60.67M-573.11M-365.43M236.10M844.94M1270.29M1569.30M3253.50M2643.50M4129.90M3537.30M-492.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 3.12M13.59M18.41M
Depreciation & Amortization (CF) 30.11M30.46M35.04M38.19M48.37M63.26M62.34M61.40M61.40M72.42M106.90M109.50M125.60M148.30M181.30M207.20M
Change in Working Capital
Change in Receivables -13.90M2.92M170.61M-39.91M-53.36M-7.43M110.10M39.09M71.76M108.15M225.60M223.40M274.70M358.60M84.10M99.30M
Change in Inventory 111.39M29.93M-7.14M16.47M23.15M19.37M47.48M31.96M64.00M132.00M92.80M136.40M322.90M517.30M
Change in Account Payables -15.06M-1.18M37.47M14.89M-49.23M25.05M-1.71M-11.74M8.75M36.55M-22.80M51.30M31.90M120.80M48.70M49.50M
Change in Accured Expenses 8.92M11.21M116.82M29.23M34.63M-63.18M102.75M-5.57M255.18M302.75M172.90M425.10M305.40M542.50M429.40M212.90M
Change in Taxes 12.07M-11.36M
Other Working Capital Changes 53.06M1.36M-71.54M-39.32M-53.01M-25.53M-19.24M73.42M111.06M-16.68M-35.40M297.60M91.80M326.40M545.70M200.30M
Investing Activities
Capital Expenditures 23.50M38.05M34.59M71.14M51.39M51.20M45.30M56.56M99.42M95.45M75.40M259.80M235.00M204.70M200.40M297.70M
Change in Intangibles 60.00M10.00M80.00M58.00M187.70M
Acquisitions 87.42M1154.20M295.90M
Change in Acquisitions & Divestments 788.26M1284.81M1016.04M1367.93M2348.30M1557.94M1067.44M757.56M369.21M431.58M475.90M437.60M499.30M920.00M839.10M4465.60M
Cash from Investing Activities -508.73M7.30M212.41M-425.82M-112.56M82.01M268.86M51.24M-483.33M-202.16M-1235.30M99.40M-340.90M-321.10M-3141.70M-3770.00M
Financing Activities
Other financing activities 0.90M-18.87M-1.25M2.16M3.10M2.08M4.80M-1.80M5.70M3.50M1.80M6.20M
Cash from Financing Activities 999.01M425.06M-124.24M172.20M248.41M549.24M188.92M133.27M68.40M-71.22M126.80M-505.30M-1478.00M-67.70M-562.20M-1494.90M
Additional items
Exchange Rate Effect -5.14M-0.38M0.21M-0.14M4.71M-2.18M-2.83M-4.67M5.80M-6.18M1.60M20.60M-13.40M-29.20M26.90M-42.60M
Change in Cash 57.54M-203.46M232.12M14.09M79.89M55.96M89.51M415.95M435.82M990.73M462.40M2868.20M811.20M3711.90M-139.70M-5800.10M
Free Cash Flow -451.08M-673.50M109.14M196.70M-112.06M-624.31M-410.73M179.54M745.52M1174.84M1493.90M2993.70M2408.50M3925.20M3336.90M-790.30M
Net Cash Flow 62.69M-203.08M231.91M14.23M75.18M58.14M92.34M420.61M430.02M996.91M460.80M2847.60M824.60M3741.10M-166.60M-5757.50M